Bobak R. Azamian - 04 Dec 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: President/CEO and Board Chair, Director
Signature: /s/ Jeffrey Farrow, Attorney-in-Fact
Issuer symbol: TARS
Transactions as of: 04 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 08 Dec 2025, 16:06:30 UTC
Previous filing: 26 Sep 2025
Next filing: 30 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Azamian Bobak R.	President/CEO and Board Chair, Director	C/O TARSUS PHARMACEUTICALS, INC., 15440 LAGUNA CANYON ROAD, SUITE 160, IRVINE	/s/ Jeffrey Farrow, Attorney-in-Fact	08 Dec 2025	0001827672

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Gift	$0	-51,885	-97%	$0.000000	1,750	04 Dec 2025	Direct	F1
holding	TARS	Common Stock						863,991	04 Dec 2025	By the Bobak Azamian Living Trust established April 16, 2018	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person transferred 51,885 shares of common stock to the Bobak Azamian Living Trust for no consideration. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.